Medistem Inc has recorded no insider trading activity within the last three months. The most recent transactions occurred in November 2013, when Chief Financial Officer Donald F. Dickerson executed several planned sales of company shares. Prior historical data shows executive buying interest dating back to 2008 and 2006.